Rankings
▼
Calendar
ALKS FY 2021 Earnings — Alkermes plc Revenue & Financial Results | Market Cap Arena
ALKS
Alkermes plc
$5B
FY 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$1.2B
+13.0% YoY
Gross Profit
$976M
83.2% margin
Operating Income
$98M
8.3% margin
Net Income
-$48M
-4.1% margin
EPS (Diluted)
$-0.30
Cash Flow
Operating Cash Flow
$102M
Free Cash Flow
$73M
Stock-Based Comp.
$88M
Balance Sheet
Total Assets
$2.0B
Total Liabilities
$912M
Stockholders' Equity
$1.1B
Cash & Equivalents
$338M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$1.2B
$1.0B
+13.0%
Gross Profit
$976M
$860M
+13.5%
Operating Income
$98M
-$112M
+186.9%
Net Income
-$48M
-$111M
+56.6%
← Q4 2020
All Quarters
Q1 2021 →